Hope Hospital, Manchester
THE concept and practice of pre-anaesthetic medication were introduced by Claude Bernard (1869) and Labbe and Goujon (1872) who administered morphine before inducing anaesthesia with chloroform. A few years later Schafer (1880) and Dastre and Morat (1884) recommended giving atropine as well as morphine. Scopolamine was first used by Schneiderlin (1903) and papaveretum (Omnopon) by Leipoldt (1911) . Despite the wide variety of agents which have since been introduced, these four drugs in various combinations remain among the most commonly used.
The several desirable actions of these drugs are unfortunately accompanied by some disadvantageous ones, foremost among which is respiratory depression. Summation of this depression of breathing with that caused by the various hypnotics and analgesics employed in anaesthesia can produce a severe diminution of effective pulmonary ventilation with all its consequences.
There have been very few studies of the action of these premedicant combinations on the respiration and the results are inadequate and sometimes conflicting. Nevertheless the findings form the basis of our present knowledge of the respiratory effects of these drugs and are authoritatively quoted in textbooks of pharmacology. The present investigation was undertaken to assess and compare the respiratory and other effects of the four combinations: morphine + atropine; morphine + scopolamine; papaveretum + atropine; and papaveretum + scopolamine; each given in a fixed dose per body weight under standard conditions.
Material and Method.
The four drug combinations were given each to 50 patients on a completely unselected basis. The 66 investigation was confined to subjects aged 20-60 years (inclusive); all were in good general condition. While it might have been more in line with clinical practice to have given the drugs by subcutaneous injection, the inequalities of depth of injection, rate of absorption, and difficulty of assuring that in all cases measurements would be made at the same time interval after administration decided in favour of the intravenous route.
The work has consisted of the measurement of pulse, blood pressure and respiratory changes, and the recording of general effects following injection of these premedication drugs. When the study was originally planned we intended to compare the hypnotic and sedative efficacy of the drug combinations. Several methods of estimating these functions were tried but none proved satisfactory under the limiting conditions of the work. This aspect of the drugs' actions was therefore excluded from the investigation. The observations were made in the anaesthetic room on patients who were about to undergo operation. The subjects breathed room air throughout. The respiratory volume was measured with a Bennett respiration meter. This meter has a very small dead space and, under the present conditions, the resistance is less than 0.25 cm H 3 O; it permits measurement to the nearest 25 ml. Serial blood pressure readings could not be taken in every case but only when skilled help was available.
The age, sex and weight distributions of the 200 patients are shown in table I. The drug dosage used throughout was: morphine 1/6 mg/kg; atropine 1/100 mg/kg; papaveretum 1/3 mg/kg; scopolamine 1/150 mg/kg. Control readings were first made; the resting pulse rate and blood pressure were taken and the rate and volume of breathing measured over a period of 1 minute. The premedication was then injected into an arm vein, a stopwatch being started at the commencement of the injection which took 10-15 seconds. The patient was asked to report any symptom or sensation immediately; no leading questions were asked. Readings of pulse, blood pressure, respiration rate and volume were made at the 3rd, 5th, 7th and 9th minutes after injection. The pressure of work in the theatre made it necessary that the patient should not be retained unduly. Therefore, as the previous work suggested that the maximum respiratory depression would have been reached by 10 minutes, the duration of the tests was limited to this time. (In a few cases the 9-minute reading had to be forgone, see table II.) At each reading the patient usually reproduced what he considered to be normal breathing. A note was made of restlessness, pruritus, wealing, etc.
RESULTS

Subjective Symptoms.
Following injection of the drugs there was an interval of 10-30 seconds before symptoms were reported. The patient's account of his sensations was largely influenced by his descriptive ability and also by the speed of his reporting. This has rendered difficult an analysis of the symptoms, for the same sensation has undoubtedly been given different names by different patients.
The symptoms frequently started in one or other arm and proceeded to the legs and/or body and/or head. Certain sensations were very common: numbness, tingling warmth, pain, and " tightness ". Other symptoms which were complained of less commonly were dizziness, palpitations, and sensations (such as fullness) in the head. A few patients complained of dryness, difficulty in breathing, " shakiness" or throbbing. Six patients denied any symptoms. Not infrequently there was a sequence of sensations starting with tightness or aching followed by heaviness, warmth, numbness, throbbing or burning, or by a few of these symptoms. Sixty-four patients reported drowsiness either spontaneously or on indirect questioning.
There was no significant difference between the incidence of these various symptoms with the four drug combinations. Almost every patient developed some flushing of the face within a few minutes of receiving his injection.
Wealing.
Linear wealing along the course of the injected vein, and sometimes its connections, occurred in 34 of the 200 patients. There was no significant difference of incidence between the four groups. The symptoms in these subjects did not differ from those of the other patients and there was no evidence of general hypersensitivity; one of these patients had no symptoms at all. Only one patient had an exaggerated general response to the premedicant drug; he did not exhibit any wealing.
Circulatory Changes.
There was no constant change in the blood pressure in the first 10 minutes after intravenous premedication with any of the four pairs of drugs. Most commonly the blood pressure did not change at all; sometimes there was a temporary rise and less often a transient fall in pressure.
The pulse showed a marked acceleration in rate in most cases (table H). The peak rate was evident at the 3rd minute and was in the order of 20-30 per cent above the control figures. From then onward there was a gradual fall but at the end of 10 minutes the rate was still 17-24 per cent above the pre-injection level. Combinations with atropine gave a significantly faster pulse than scopolamine combinations except that M+A was similar to
M + S.
Respiratory Changes.
Rate. The drug combinations had little effect on the respiration rate (table ILT) . There was no (table IV) . The fall occurred chiefly in the first 3 minutes but the volume continued to decline, although more gradually, throughout the first 10 minutes after administration.
Drug combinations containing papaveretum were more depressant to the respiration than those containing morphine. Comparing M+A with P + A and with P + S the morphine combination is significantly less depressant at most time intervals. Comparing M + S with P + A and with P + S the morphine combination is significantly less depressant at most time intervals.
There appears to be no difference between the effects exerted by atropine and scopolamine.
Tidal Volume. As would be expected from the rate and minute volume changes there was a fall in tidal volume in all four series. The smallest deviation from the control volumes was after morphine + atropine and the greatest depression was caused by papaveretum + scopolamine (table V) . These changes will, of course, be reflected in the effective ventilation. There was no significant difference between the effects of atropine and scopolamine at the level of significance adopted in this work (i.e. P<0.05). However, comparison of M + A and M+S suggests that the latter may be the more depressant, for there is a significant difference at the 7 per cent level at some time intervals. It is evident that the drug combinations investigated produce a marked respiratory depression in clinical dosage. The effect on the respiration of the individual drugs has been investigated by several workers but the combinations, as used in clinical practice, have been very inadequately studied. No previous investigation of the papaveretum combinations has been discovered. Waters (1938) administered 16 mg morphine with either 0.64 mg scopolamine or 1.28 mg atropine to 10 adult male volunteers. Halfhourly readings were taken before and for 7 hours after hypodermic injection. He found that the atropine combination caused the greater depression of respiratory minute volume and that neither mixture had much effect on the respiratory rate. Wangeman and Hawk (1942) administered the same two drug combinations in the same dosages hypodermically to 5 trained volunteers and took readings at 15-minute intervals for 1± hours. They found that morphine + atropine caused a marked early rise in pulse rate, a variable effect on the blood pressure, respiration rate and tidal volume, and a depression of the minute volume. Morphine + scopolamine caused an inconstant change in pulse rate and blood pressure, some decrease in respiratory rate and a slight decrease in minute volume. Adriani (1954) states that morphine and atropine, given in a ratio of 25 :1, cause " a moderate decrease " in minute volume and some elevation of pulse rate. Morphine and scopolamine in 25:1 ratio are stated to cause a slight decrease in minute volume and no change in heart rate.
It will be seen that the present results are at variance with some of the previous findings. However, the other workers used very small series of cases, the dosages were different from the present ones, and the drugs were not administered on a dose per weight basis. The large individual variation in respiratory response to these drugs must also be borne in mind.
Ideally in an investigation of premedicant drugs the route of administration should be that commonly used in clinical practice. Although, for experimental expedience, the intravenous route was used here there is evidence to show that the present findings, both absolute and relative, are directly related to clinical practice. Thus Dripps and Comroe (1945) have shown that " the maximum respiratory depression following morphine is approximately the same whether the morphine be administered intravenously or intramuscularly ", and Adriani (1954) considers that the effect of these drug combinations 10 minutes after • intravenous administration is the same as that 1£ hours after subcutaneous injection.
The use of the intravenous route for premedication will, of course, deny the patient the benefits of pre-operative sedation and cannot, therefore, be advocated for general use. However, occasions will arise when this route has to be used, as in an emergency, in the shocked patient, when premedication has been overlooked, or to supplement an inadequate or badly timed dose (Foldes and Swerdlow, 1954) . Intravenous administration does ensure rapid action and absorption regardless of circulatory efficiency and has the further advantage that the full effect can be seen before anaesthesia is commenced. A disadvantage, an impression noted in the present work, is that patients tend to sleep longer postoperative^ than after conventional hypodermic premedication. If thiopentone is to be used following intravenous premedication the dose should be reduced to avoid severe respiratory depression (Swerdlow, 1957 ).
The present investigation shows unequivocally that in clinical dosage combinations with morphine will cause significantly less depression of the respiration than papaveretum mixtures. From the point of view of respiratory depression alone there is a suggestion that atropine might be preferable to scopolamine for combination with morphine. However, Orkin and his colleagues (1956), Wangeman and Hawk (1942) and others accord to scopolamine a much greater drying effect and psychic depression than atropine. Taking into account also the amnesic properties of scopolamine and its lesser effect on the heart rate the balance might be inclined in its favour except at the extremes of age where its use is commonly avoided.
SUMMARY
Morphine and papaveretum, in combinations with atropine and scopolamine, have been administered intravenously in fixed dose per body weight to 200 patients. Changes in pulse, blood pressure, respiration rate and depth were recorded at intervals up to 10 minutes after injection and general effects noted.
The blood pressure showed no constant change. A rise in pulse rate occurred after all combinations and was generally greater after atropine mixtures. The respiration rate showed no significant change. The respiratory volume was diminished by all drug combinations, papaveretum causing a significantly greater depression than morphine.
